Barclays PLC Buys 174,997 Shares of Tilray Inc (NASDAQ:TLRY)

Barclays PLC raised its holdings in Tilray Inc (NASDAQ:TLRY) by 600.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 204,144 shares of the company’s stock after acquiring an additional 174,997 shares during the quarter. Barclays PLC’s holdings in Tilray were worth $359,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ferguson Wellman Capital Management Inc. bought a new position in Tilray in the third quarter valued at approximately $26,000. Vanguard Capital Wealth Advisors bought a new position in Tilray in the second quarter valued at approximately $34,000. Vista Capital Partners Inc. bought a new position in Tilray in the third quarter valued at approximately $42,000. International Assets Investment Management LLC boosted its stake in Tilray by 335.3% in the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock valued at $42,000 after acquiring an additional 18,208 shares during the last quarter. Finally, Capital Management Associates Inc bought a new position in Tilray in the third quarter valued at approximately $45,000. 9.35% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CFO Carl A. Merton acquired 26,000 shares of the company’s stock in a transaction that occurred on Friday, November 15th. The shares were acquired at an average cost of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the acquisition, the chief financial officer now directly owns 26,000 shares in the company, valued at approximately $35,360. The trade was a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.87% of the stock is currently owned by company insiders.

Tilray Trading Down 0.7 %

Shares of NASDAQ TLRY opened at $1.45 on Friday. The company’s fifty day moving average is $1.40 and its 200-day moving average is $1.63. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -5.37 and a beta of 2.08. Tilray Inc has a twelve month low of $1.14 and a twelve month high of $2.97. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). The company had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.10) earnings per share. Equities research analysts predict that Tilray Inc will post -0.14 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm reduced their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.